{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:33:17Z","timestamp":1790742797307,"version":"4.1.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1097\/00000441-200410000-00007","type":"journal-article","created":{"date-parts":[[2004,10,5]],"date-time":"2004-10-05T08:17:54Z","timestamp":1096964274000},"page":"238-247","source":"Crossref","is-referenced-by-count":38,"title":["The Endocrine System during Sepsis"],"prefix":"10.1016","volume":"328","author":[{"given":"Stephen","family":"Brierre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bennett P.","family":"Deboisblanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rekha","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/00000441-200410000-00007_bb0005","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1210\/jcem.87.3.8341","article-title":"Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes [comment]","volume":"87","author":"Umpierrez","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1097\/00000441-200410000-00007_bb0010","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1146\/annurev.nu.09.070189.002305","article-title":"The effects of injury and sepsis on fuel utilization","volume":"9","author":"Goldstein","year":"1989","journal-title":"Annu Rev Nutr"},{"key":"10.1097\/00000441-200410000-00007_bb0015","first-page":"731","article-title":"Alterations of blood glucose homeostasis during septic or injury stress\u2013hyperglycemia [in Polish]","volume":"55","author":"Buczkowska","year":"2002","journal-title":"Wiad Lek"},{"key":"10.1097\/00000441-200410000-00007_bb0020","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1042\/cs0990321","article-title":"Insulin sensitivity of glucose and fat metabolism in severe sepsis","volume":"99","author":"Chambrier","year":"2000","journal-title":"Clin Sci"},{"key":"10.1097\/00000441-200410000-00007_bb0025","first-page":"100","article-title":"Impaired glucose and lipid metabolism seen in intensive care patients is related to severity of illness and survival","volume":"5","author":"Lind","year":"1994","journal-title":"Clin Intens Care"},{"key":"10.1097\/00000441-200410000-00007_bb0030","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.4065\/78.12.1471","article-title":"Association between hyperglycemia and increased hospital mortality in a heterogenous population of critically ill patients","volume":"78","author":"Krinsley","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"10.1097\/00000441-200410000-00007_bb0035","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2337\/diab.27.6.677","article-title":"Impaired granulocyte adherence: a reversible defect in host defense in patients with poorly controlled diabetes","volume":"27","author":"Bagdade","year":"1978","journal-title":"Diabetes"},{"key":"10.1097\/00000441-200410000-00007_bb0040","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF01650754","article-title":"Polymorphonuclear leucocyte dysfunction during short term metabolic changes from normo- to hyperglycemia in type 1 (insulin dependent) diabetic patients","volume":"16","author":"Kjersem","year":"1988","journal-title":"Infection"},{"key":"10.1097\/00000441-200410000-00007_bb0045","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1006\/mgme.2001.3185","article-title":"Impairment of type III group B Streptococcus-stimulated superoxide production and opsonophagocytosis by neutrophils in diabetes","volume":"73","author":"Mazade","year":"2001","journal-title":"Mol Genet Metab"},{"key":"10.1097\/00000441-200410000-00007_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0891-5520(20)30637-1","article-title":"Host defenses and susceptibility to infection in patients with diabetes mellitus","volume":"9","author":"McMahon","year":"1995","journal-title":"Infect Dis Clin North Am"},{"key":"10.1097\/00000441-200410000-00007_bb0055","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1056\/NEJM197103252841201","article-title":"Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus","volume":"284","author":"Mowat","year":"1971","journal-title":"N Engl J Med"},{"key":"10.1097\/00000441-200410000-00007_bb0060","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1023\/A:1027399921351","article-title":"Effects of D-glucose on chemokinesis and resting production of reactive oxygen species in neutrophil granulocytes of lean or obese-hyperglycemic mouse","volume":"17","author":"Oldenborg","year":"1997","journal-title":"Biosci Rep"},{"key":"10.1097\/00000441-200410000-00007_bb0065","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/jlb.65.5.635","article-title":"Hyperglycemia in vitro attenuates insulin-stimulated chemokinesis in normal human neutrophils. Role of protein kinase C activation","volume":"65","author":"Oldenborg","year":"1999","journal-title":"J Leukoc Biol"},{"key":"10.1097\/00000441-200410000-00007_bb0070","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0094-1298(02)00066-4","article-title":"Wound healing and diabetes mellitus","volume":"30","author":"Greenhalgh","year":"2003","journal-title":"Clin Plastic Surg"},{"key":"10.1097\/00000441-200410000-00007_bb0075","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1210\/jcem.85.8.6854","article-title":"Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes","volume":"85","author":"Mohanty","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1097\/00000441-200410000-00007_bb0080","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1161\/01.CIR.0000034509.14906.AE","article-title":"Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress","volume":"106","author":"Esposito","year":"2002","journal-title":"Circulation"},{"key":"10.1097\/00000441-200410000-00007_bb0085","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000206901","article-title":"Diabetes, a hypercoagulable state? Hemostatic variables in newly diagnosed type 2 diabetic patients","volume":"69","author":"Hughes","year":"1983","journal-title":"Acta Haematol"},{"key":"10.1097\/00000441-200410000-00007_bb0090","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0140-6736(94)90939-3","article-title":"Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias","volume":"343","author":"Oliver","year":"1994","journal-title":"Lancet"},{"issue":"Suppl 2","key":"10.1097\/00000441-200410000-00007_bb0095","doi-asserted-by":"crossref","first-page":"S180","DOI":"10.1055\/s-2001-18580","article-title":"Pathogenesis of dyslipidemia in type 2 diabetes","volume":"109","author":"Taskinen","year":"2001","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1097\/00000441-200410000-00007_bb0100","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1007\/s00125-002-0965-8","article-title":"Elevated post-prandial free fatty acids are associated with cardiac sympathetic overactivity in Type II diabetic patients","volume":"45","author":"Manzella","year":"2002","journal-title":"Diabetologia"},{"key":"10.1097\/00000441-200410000-00007_bb0105","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0272-6386(97)90089-5","article-title":"Factors contributing to the degree of polyuria in a patient with poorly controlled diabetes mellitus","volume":"30","author":"Spira","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1097\/00000441-200410000-00007_bb0110","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.3748\/wjg.v9.i8.1824","article-title":"Influence of acute hyperglycemia in human sepsis on inflammatory cytokine and counterregulatory hormone concentrations","volume":"9","author":"Yu","year":"2003","journal-title":"World J Gastroenterol"},{"key":"10.1097\/00000441-200410000-00007_bb0115","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.2337\/diacare.22.9.1408","article-title":"Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes","volume":"22","author":"Golden","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1097\/00000441-200410000-00007_bb0120","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1086\/502133","article-title":"Elevated preoperative fasting serum glucose levels increase the risk of postoperative mediastinitis in patients undergoing open heart surgery","volume":"24","author":"Wilson","year":"2003","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1097\/00000441-200410000-00007_bb0125","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0735-1097(95)00126-K","article-title":"Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1year (comment)","volume":"26","author":"Malmberg","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1097\/00000441-200410000-00007_bb0130","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1056\/NEJMoa011300","article-title":"Intensive insulin therapy in the critically ill patients","volume":"345","author":"van den Berghe","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1097\/00000441-200410000-00007_bb0135","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/0002-9149(62)90035-8","article-title":"Effects of an intravenous infusion of a potassium-glucose-insulin solution on the EKG signs of myocardial infarction","volume":"9","author":"Sodi-Pallares","year":"1962","journal-title":"Am J Cardiol"},{"key":"10.1097\/00000441-200410000-00007_bb0140","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/01.CCM.0000045568.12881.10","article-title":"Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control (comment)","volume":"31","author":"Van den Berghe","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1097\/00000441-200410000-00007_bb0145","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1098-3597(03)90018-4","article-title":"Insulin therapy for the critically ill patient","volume":"5","author":"Van den Berghe","year":"2003","journal-title":"Clin Cornerstone"},{"key":"10.1097\/00000441-200410000-00007_bb0150","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1007\/s00125-001-0766-5","article-title":"The anti-inflammatory and potential anti-atherogenic effect of insulin: a new paradigm","volume":"45","author":"Dandona","year":"2002","journal-title":"Diabetologia"},{"key":"10.1097\/00000441-200410000-00007_bb0155","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1210\/jcem.87.3.8462","article-title":"Insulin inhibits the pro-inflammatory transcription factor early growth response gene-1 (Egr)-1 expression in mononuclear cells (MNC) and reduces plasma tissue factor (TF) and plasminogen activator inhibitor-1 (PAI-1) concentrations","volume":"87","author":"Aljada","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1097\/00000441-200410000-00007_bb0160","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1001\/jama.290.15.2041","article-title":"Glucose control and mortality in critically ill patients","volume":"290","author":"Finney","year":"2003","journal-title":"JAMA"},{"key":"10.1097\/00000441-200410000-00007_bb0165","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1210\/jc.2003-030347","article-title":"The rationale and management of hyperglycemia for in-patients with cardiovascular disease: time for change","volume":"88","author":"Trence","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1097\/00000441-200410000-00007_bb0170","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(03)13492-7","article-title":"Adrenal insufficiency","volume":"361","author":"Arlt","year":"2003","journal-title":"Lancet"},{"key":"10.1097\/00000441-200410000-00007_bb0175","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1097\/01.CCM.0000063447.37342.A9","article-title":"Glucocorticoid insufficiency in patients who present to the hospital with severe sepsis: a prospective clinical trial","volume":"31","author":"Manlik","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1097\/00000441-200410000-00007_bb0180","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00003246-200301000-00022","article-title":"Adrenal insufficiency during septic shock","volume":"31","author":"Marik","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1097\/00000441-200410000-00007_bb0185","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00003246-200301000-00059","article-title":"Defining adrenal insufficiency in septic shock","volume":"31","author":"Kenyon","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1097\/00000441-200410000-00007_bb0190","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1097\/01.CCM.0000063445.91548.20","article-title":"Time for a consensus definition of corticosteroid insufficiency in critically ill patients","volume":"31","author":"Annane","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1097\/00000441-200410000-00007_bb0195","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1001\/jama.283.8.1038","article-title":"A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotrophin","volume":"283","author":"Annane","year":"2000","journal-title":"JAMA"},{"key":"10.1097\/00000441-200410000-00007_bb0200","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/0140-6736(91)91641-7","article-title":"Cortisol response to corticotropin and survival in septic shock","volume":"337","author":"Rothwell","year":"1991","journal-title":"Lancet"},{"key":"10.1097\/00000441-200410000-00007_bb0205","first-page":"A163","article-title":"Secondary adrenal insufficiency is common in critically ill patients","volume":"29","author":"Marik","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1097\/00000441-200410000-00007_bb0210","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1056\/NEJMoa020266","article-title":"Measurements of serum free cortisol in critically ill patients","volume":"350","author":"Mamrahian","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1097\/00000441-200410000-00007_bb0215","first-page":"166","article-title":"The effectiveness of hydrocortisone in the management of severe infections","volume":"183","author":"Bennett","year":"1963","journal-title":"JAMA"},{"key":"10.1097\/00000441-200410000-00007_bb0220","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00000658-197609000-00011","article-title":"Steroids in the treatment of clinical septic shock","volume":"184","author":"Shumer","year":"1976","journal-title":"Ann Surg"},{"key":"10.1097\/00000441-200410000-00007_bb0225","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1056\/NEJM198411013111801","article-title":"The effects of high-dose corticosteroids in patients with septic shock","volume":"311","author":"Sprung","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1097\/00000441-200410000-00007_bb0230","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJM198709103171101","article-title":"A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock","volume":"317","author":"Bone","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1097\/00000441-200410000-00007_bb0235","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1056\/NEJM198709103171102","article-title":"Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. The Veterans Administration Systemic Sepsis Cooperative Study Group","volume":"317","author":"Anonymous","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1097\/00000441-200410000-00007_bb0240","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1097\/00003246-199508000-00019","article-title":"Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature","volume":"23","author":"Cronin","year":"1995","journal-title":"Crit Care Med"},{"key":"10.1097\/00000441-200410000-00007_bb0245","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1097\/00003246-199507000-00021","article-title":"Steroid controversy in sepsis and septic shock: a meta-analysis","volume":"23","author":"Lefering","year":"1995","journal-title":"Crit Care Med"},{"key":"10.1097\/00000441-200410000-00007_bb0250","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1046\/j.1365-2125.1998.00833.x","article-title":"Impaired pressor sensitivity to noradrenaline in septic shock patients with and without impaired adrenal function reserve","volume":"46","author":"Annane","year":"1998","journal-title":"Br J Clin Pharmacol"},{"key":"10.1097\/00000441-200410000-00007_bb0255","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/00003246-199804000-00010","article-title":"Reversal of late septic shock with supraphysiologic doses of hydrocortisone","volume":"26","author":"Bollaert","year":"1998","journal-title":"Crit Care Med"},{"key":"10.1097\/00000441-200410000-00007_bb0260","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/00003246-199904000-00025","article-title":"Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study","volume":"27","author":"Briegel","year":"1999","journal-title":"Crit Care Med"},{"key":"10.1097\/00000441-200410000-00007_bb0265","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/jama.288.7.862","article-title":"Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock","volume":"288","author":"Annane","year":"2002","journal-title":"JAMA"},{"key":"10.1097\/00000441-200410000-00007_bb0270","first-page":"259","article-title":"Diagnosis and therapy surveillance in Addison\u2019s disease: rapid adrenocorticotropin (ACTH) test and measurement of plasma ACTH, renin activity, and aldosterone","volume":"75","author":"Oelkers","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1097\/00000441-200410000-00007_bb0275","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1056\/NEJM199901213400307","article-title":"Treating patients with severe sepsis","volume":"340","author":"Wheeler","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1097\/00000441-200410000-00007_bb0280","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/00003246-199603000-00026","article-title":"Is it time to reposition vasopressors and inotropes in sepsis?","volume":"24","author":"Rudis","year":"1996","journal-title":"Crit Care Med"},{"key":"10.1097\/00000441-200410000-00007_bb0285","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1378\/chest.103.6.1826","article-title":"Norepinephrine or dopamine for the treatment of hyperdynamic septic shock","volume":"103","author":"Martin","year":"1993","journal-title":"Chest"},{"key":"10.1097\/00000441-200410000-00007_bb0290","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s001340050329","article-title":"Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized study","volume":"23","author":"Levy","year":"1997","journal-title":"Intens Care Med"},{"key":"10.1097\/00000441-200410000-00007_bb0295","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1097\/00003246-199111000-00016","article-title":"Experience with phenylephrine as a component of the pharmacologic support of septic shock","volume":"19","author":"Gregory","year":"1991","journal-title":"Crit Care Med"},{"key":"10.1097\/00000441-200410000-00007_bb0300","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/00003246-198710000-00006","article-title":"Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: heart rate as an early predictor of prognosis","volume":"15","author":"Parker","year":"1987","journal-title":"Crit Care Med"},{"key":"10.1097\/00000441-200410000-00007_bb0305","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0024-3205(00)00978-4","article-title":"Hyperpolarization contributes to vascular hyperreactivity in rats with lipopolysaccharide-induced endotoxic shock","volume":"68","author":"Chen","year":"2000","journal-title":"Life Sci"},{"key":"10.1097\/00000441-200410000-00007_bb0310","first-page":"H1087","article-title":"Enhancement by vasopressin of adrenergic responses in human mesenteric arteries","volume":"272","author":"Medina","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1097\/00000441-200410000-00007_bb0315","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1213\/00000539-199903000-00015","article-title":"The effects of vasopressin on endotoxin-induced attenuation of contractile responses in human gastroepiploic arteries in vitro","volume":"88","author":"Hamu","year":"1999","journal-title":"Anesth Analg"},{"key":"10.1097\/00000441-200410000-00007_bb0320","doi-asserted-by":"crossref","first-page":"132A","DOI":"10.1097\/00003246-199901001-00366","article-title":"Comparative physiologic effects of vasopressin, norepinephrine, and phenylephrine in the treatment of septic shock","volume":"27","author":"Malay","year":"1999","journal-title":"Crit Care Med"},{"key":"10.1097\/00000441-200410000-00007_bb0325","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1097\/01.CCM.0000063046.82359.4A","article-title":"Circulating vasopressin levels in septic shock","volume":"31","author":"Sharshar","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1097\/00000441-200410000-00007_bb0330","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1161\/01.CIR.95.5.1122","article-title":"Vasopressin deficiency contributes to the vasodilation of septic shock","volume":"95","author":"Landry","year":"1997","journal-title":"Circulation"},{"key":"10.1097\/00000441-200410000-00007_bb0335","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1378\/chest.120.3.989","article-title":"Physiology of vasopressin relevant to management of septic shock","volume":"120","author":"Holmes","year":"2001","journal-title":"Chest"},{"key":"10.1097\/00000441-200410000-00007_bb0340","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00003246-200203000-00001","article-title":"Depletion of neurohypophyseal content of vasopressin in septic shock","volume":"30","author":"Sharshar","year":"2002","journal-title":"Crit Care Med"},{"key":"10.1097\/00000441-200410000-00007_bb0345","first-page":"R524","article-title":"Role of V1 receptors in the action of vasopressin on the baroreflex control of heart rate","volume":"265","author":"Luk","year":"1993","journal-title":"Am J Physiol"},{"key":"10.1097\/00000441-200410000-00007_bb0350","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0272-5231(05)70311-7","article-title":"Cardiac dysfunction during septic shock","volume":"17","author":"Bunnell","year":"1996","journal-title":"Clin Chest Med"},{"key":"10.1097\/00000441-200410000-00007_bb0355","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/00003246-199708000-00012","article-title":"Vasopressin pressor hypersensitivity in vasodilatory septic shock","volume":"25","author":"Landry","year":"1997","journal-title":"Crit Care Med"},{"key":"10.1097\/00000441-200410000-00007_bb0360","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/00005373-199910000-00014","article-title":"Low-dose vasopressin in the treatment of vasodilatory septic shock","volume":"47","author":"Malay","year":"1999","journal-title":"J Trauma"},{"key":"10.1097\/00000441-200410000-00007_bb0365","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/00003246-200103000-00004","article-title":"Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock","volume":"29","author":"Tsuneyoshi","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1097\/00000441-200410000-00007_bb0370","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/00000542-200203000-00011","article-title":"Beneficial effects of short-term vasopressin infusion during severe septic shock","volume":"96","author":"Patel","year":"2002","journal-title":"Anesthesiology"},{"key":"10.1097\/00000441-200410000-00007_bb0375","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1097\/01.CCM.0000094260.05266.F4","article-title":"High-dose vasopressin is not superior to norepinephrine in septic shock","volume":"31","author":"Klinzing","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1097\/00000441-200410000-00007_bb0380","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1210\/jcem.82.2.3745","article-title":"Euthyroid sick syndrome: is it a misnomer?","volume":"82","author":"Chopra","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1097\/00000441-200410000-00007_bb0385","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/jama.1981.03310260021020","article-title":"Hypothyroxenemia in critically ill patients as predictor of high mortality","volume":"245","author":"Slag","year":"1981","journal-title":"JAMA"},{"key":"10.1097\/00000441-200410000-00007_bb0390","series-title":"Werner & Ingbar\u2019s The thyroid: a fundamental and clinical text.","first-page":"121","article-title":"Nonthyroidal illness","author":"Wiersinga","year":"2000"},{"key":"10.1097\/00000441-200410000-00007_bb0395","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S0022-5223(99)70249-7","article-title":"A randomized double-blind study of the effect of triiodothyronine on cardiac function and morbidity after coronary bypass surgery","volume":"117","author":"Mullis-Jansson","year":"1999","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1097\/00000441-200410000-00007_bb0400","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1056\/NEJM199512073332302","article-title":"Thyroid hormone treatment after coronary artery bypass surgery","volume":"333","author":"Klemperer","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1097\/00000441-200410000-00007_bb0405","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1001\/jama.1996.03530330031025","article-title":"Cardiovascular effect of intravenous triiodothyronine in patients undergoing coronary artery bypass graft surgery: randomized, double blind placebo controlled trial","volume":"275","author":"Bennet-Guerrero","year":"1996","journal-title":"JAMA"},{"key":"10.1097\/00000441-200410000-00007_bb0410","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/jcem-63-1-1","article-title":"Thyroxine therapy in patients with severe nonthyroidal illnesses and low serum thyroxine concentration","volume":"63","author":"Brent","year":"1986","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915339781?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915339781?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T05:43:55Z","timestamp":1624686235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962915339781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":82,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["S0002962915339781"],"URL":"https:\/\/doi.org\/10.1097\/00000441-200410000-00007","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2004,10]]}}}